Ling Yui Holdings Limited: Closure of Mandatory Cash Offer, Shareholding Structure, and Public Float Update

Key Points in the Announcement

• Closure of Offer: The unconditional mandatory cash offer made by Hapbiotech Investment Holding Limited (“Offeror”) to acquire all issued shares in Ling Yui Holdings Limited (other than those already owned or agreed to be acquired by the Offeror and parties acting in concert) has officially closed at 4:00 p.m. on Tuesday, 26 May 2026. The offer was not revised or extended.
• Offer Acceptance: Only five valid acceptances were received, covering a total of 90,000 Offer Shares—representing a mere 0.01% of the Company’s entire issued share capital.
• Offer Price and Settlement: The Offer Price was HK\$0.2375 per share, totalling HK\$21,375 for all accepted shares. Remittances, after deducting Hong Kong ad valorem stamp duty, will be sent to accepting shareholders no later than 4 June 2026.
• Shareholding Structure Update:
  • Prior to the Offer period, the Offeror and its concert parties held no shares or voting rights.
  • Immediately following Completion, they held 560,140,000 shares (70.02% of issued share capital).
  • After the Offer close (and upon transfer registration), they will hold 560,230,000 shares (70.03%).
  • Public shareholders will own 239,770,000 shares (29.97%).
• Public Float: Ling Yui Holdings continues to meet the minimum public float requirement of 25% as per HKEX Listing Rule 8.08(1)(a), with 29.97% held by the public.
• Board and Directors’ Responsibility: The Board of Ling Yui Holdings and the directors of the Offeror have confirmed the accuracy of the information provided in the announcement.

Important Information for Shareholders

• Price-sensitive Information:
  • Low uptake of the offer (only 0.01% accepted) may signal shareholder confidence or lack of interest at the Offer Price.
  • Offeror’s controlling stake increases slightly to 70.03%; this could affect future corporate actions, governance, and potential market liquidity.
  • Public float remains above the regulatory threshold, so risk of trading suspension due to insufficient float is low.
• Potential Impact on Share Value:
  • The limited response to the Offer and the continued compliance with public float requirements is a stabilizing factor for share value.
  • Shareholders should monitor any future moves or announcements by the Offeror regarding strategic changes, further acquisitions, or privatization attempts.
  • The Offer Price (HK\$0.2375) sets a recent transactional reference point for the share valuation.
• Settlement Timeline: Cash payments for accepted shares will reach shareholders by ordinary post no later than 4 June 2026.
• Corporate Governance: Board composition remains unchanged, with both executive and independent directors listed. This stability may reassure investors.

Detailed Shareholding Table

Conclusion

The closure of the mandatory cash offer with minimal shareholder acceptance and continued compliance with public float requirements are key stabilizing factors for Ling Yui Holdings. Investors should remain alert to any future corporate actions by the Offeror, given its significant controlling stake and the reference Offer Price.

Disclaimer

This article is for informational purposes only and does not constitute investment advice. Investors should exercise their own judgment and consult professional advisers before making any investment decisions. The author and publisher accept no liability for any loss arising from reliance on the information in this article.

嶺睿控股有限公司：強制現金要約結束及股權結構、公開持股更新

公告重點

• 要約結束： Hapbiotech Investment Holding Limited（要約人）向嶺睿控股有限公司發出的無條件強制現金要約已於2026年5月26日（星期二）下午4時正式結束，並未被修訂或延長。
• 要約接受情況： 只收到五份有效接受，涉及總共90,000股要約股份，僅佔公司已發行股本的0.01%。
• 要約價格及結算： 要約價格為每股HK\$0.2375，所有接受股份的總對價為HK\$21,375。扣除香港印花稅後，款項將於2026年6月4日或之前以平郵方式寄出。
• 股權結構更新：
  • 要約期間前，要約人及一致行動人士並未持有任何股份或投票權。
  • 完成交易後要約人及一致行動人士持有560,140,000股，佔已發行股本70.02%。
  • 要約結束後（並完成股份轉讓登記），持有560,230,000股，佔70.03%。
  • 公眾股東持有239,770,000股，佔29.97%。
• 公開持股： 嶺睿控股繼續符合港交所上市規則8.08(1)(a)要求，公眾持股佔29.97%，高於25%最低要求。
• 董事及責任： 嶺睿控股董事會及要約人董事均確認公告信息準確無誤。

股東需注意的重要事項

• 可能影響股價的信息：
  • 要約接受率極低（僅0.01%），或反映股東對要約價信心或缺乏興趣。
  • 要約人持股略微提升至70.03%，可能影響未來公司治理、企業行動及市場流動性。
  • 公開持股比例高於監管要求，暫無因公開持股不足而停牌風險。
• 對股價的潛在影響：
  • 要約反應冷淡及公開持股充足，有助穩定股價。
  • 股東應密切關注要約人未來是否有進一步收購、私有化或企業策略變動。
  • 要約價（HK\$0.2375）可作為近期股份估值參考。
• 結算時間： 接受要約的股東將於2026年6月4日或之前收到現金款項。
• 公司治理： 董事會成員及架構維持不變，對投資者屬於穩定因素。

詳細股權表

總結

強制現金要約結束，接受率極低，公司公開持股比例充足，有助股價穩定。投資者應留意要約人未來的動向，包括企業策略、進一步收購或私有化計劃，並以要約價作為股值參考。

免責聲明

本文章僅供參考，不構成任何投資建議。投資者應自行判斷及諮詢專業顧問，作者及發布者對任何因依賴本文章所導致的損失概不負責。

View LING YUI Historical chart here